Pneumonia Vaccine Market Size And Share

  • Report Code : TIPRE00008672
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Marktgröße für Lungenentzündungsimpfstoffe, Anteilsanalyse bis 2025-2031

Buy Now

Pneumonia Vaccine Market Report Pneumonia Vaccine Market Scope and Analysis Pneumonia Vaccine Market Size and Share

Pneumonia Vaccine Market Report Analysis

Pneumonia Vaccine Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Pfizer
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.

Regional Overview

  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Naher Osten und Afrika

Market Segmentation

By Impfstofftyp [Pneumokokken-Polysaccharid-Impfstoff
  • PPSV/PPV
  • Pneumokokken-Konjugat-Impfstoff
By Produkttyp
  • Prevnar 13
  • Synflorix
  • Pneumovax23
By Vertriebskanal
  • Krankenhausapotheken
  • Einzelhandelsapotheken
  • Sonstige
By Geographie
  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika